Home › Cases › Mesenteric Venous Thrombosis
Mesenteric Ischaemia
Mesenteric Venous Thrombosis
6 questions
Question 1 · A different pattern
Correct answer: Mesenteric venous thrombosis — a subacute presentation in a younger patient with thrombophilia risk
Why
Mesenteric venous thrombosis presents differently from arterial disease: younger patients, a subacute course over days, and a background of thrombophilia, previous VTE, malignancy, cirrhosis or recent abdominal surgery. Arterial embolic disease is abrupt. Loose stool here is a red herring that frequently leads to a gastroenteritis label.
Key point
Venous mesenteric thrombosis is subacute, in younger patients, with a thrombotic history.
Question 2 · Imaging
Correct answer: CT with contrast including portal venous phase, to look for thrombus in the mesenteric and portal veins
Why
Venous thrombosis is best seen on portal venous phase contrast CT, which shows thrombus in the superior mesenteric or portal vein with bowel wall thickening and mesenteric oedema. This is a different request from arterial-phase CTA — another reason to state the clinical question. Ultrasound is unreliable for this.
Key point
Portal venous phase for venous thrombosis; arterial phase for embolic disease. Say which you want.
Question 3 · Treatment
Correct answer: Therapeutic anticoagulation, with surgical involvement and close observation for deterioration
Why
Unlike arterial occlusion, uncomplicated mesenteric venous thrombosis is treated medically with therapeutic anticoagulation, alongside bowel rest, fluids and surgical involvement in case of deterioration. Surgery is reserved for infarction or perforation. This difference between arterial and venous disease is the key learning point.
Key point
Venous thrombosis without infarction is treated with anticoagulation, not resection.
Question 4 · Underlying cause
Correct answer: Investigate for an underlying prothrombotic cause — thrombophilia, malignancy, myeloproliferative disease, liver disease
Why
Mesenteric venous thrombosis is frequently secondary, and finding the cause changes long-term management including the duration of anticoagulation. Look for inherited and acquired thrombophilia, myeloproliferative disorders (including JAK2), malignancy, cirrhosis and portal hypertension. Acute colonoscopy is not indicated and carries risk.
Key point
Look for the cause — it determines how long anticoagulation continues.
Question 5 · Deterioration
Correct answer: Urgent surgical review for laparotomy — this suggests infarction despite anticoagulation
Why
Peritonism with a rising lactate indicates infarction, and anticoagulation cannot salvage dead bowel. This is the trigger for urgent surgical review and probable laparotomy. Escalating anticoagulation or waiting a further day for imaging in a patient with peritonism is a delay that costs bowel and life.
Key point
Anticoagulation is the plan until peritonism appears — then it is a surgical problem.
Question 6 · Duration
Correct answer: At least 3–6 months, and potentially lifelong if an ongoing prothrombotic cause is identified — a haematology decision
Why
Duration follows the same logic as other venous thromboembolism: a minimum of 3–6 months, extended or made lifelong where an ongoing prothrombotic state is found. That decision belongs with haematology and depends on the results of the thrombophilia and malignancy work-up, not on symptom resolution.
Key point
3–6 months minimum, longer if the cause persists — decided with haematology.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.